Please use this identifier to cite or link to this item:
https://doi.org/10.1371/journal.pone.0180949
Title: | Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore | Authors: | Zhang X. Low S. Kumari N. Wang J. Ang K. Yeo D. Yip C.C. Tavintharan S. Sum C.F. Lim S.C. |
Keywords: | adult aged Article chronic kidney failure controlled study cost difference cost of illness diabetic retinopathy digital color fundus photograph direct medical cost disease association disease classification disease severity female hospital management human major clinical study male middle aged neuropathy non insulin dependent diabetes mellitus non proliferative diabetic retinopathy photography proliferative diabetic retinopathy prophylaxis retinopathy Singapore smoking very elderly body mass diabetic retinopathy disease course economics non insulin dependent diabetes mellitus pathology young adult Adult Aged Body Mass Index Diabetes Mellitus, Type 2 Diabetic Retinopathy Disease Progression Female Humans Male Middle Aged Renal Insufficiency, Chronic Singapore Young Adult |
Issue Date: | 2017 | Citation: | Zhang X., Low S., Kumari N., Wang J., Ang K., Yeo D., Yip C.C., Tavintharan S., Sum C.F., Lim S.C. (2017). Direct medical cost associated with diabetic retinopathy severity in type 2 diabetes in Singapore. PLoS ONE 12 (7) : e0180949. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0180949 | Rights: | Attribution 4.0 International | Abstract: | Diabetic retinopathy (DR) is a leading cause of vision-loss globally among type 2 diabetes (T2DM) patients. Information on the economic burden of DR in Singapore is limited. We aim to identify the total annual direct medical costs of DR at different stages, and to examine factors influencing the costs. Four hundreds and seventy T2DM patients who attended the Diabetes Centre in a secondary hospital in Singapore in 2011–2014 were included. Digital color fundus photographs were assessed for DR in a masked fashion. Retinopathy severity was further categorized into non-proliferative DR (NPDR), including mild, moderate and severe NPDR, and proliferative DR (PDR). Medical costs were assessed using hospital administrative data. DR was diagnosed in 172 (39.5%) patients, including 51 mild, 62 moderate and 18 severe NPDR, and 41 PDR. The median cost in DR [2012.0 (1111.2–4192.3)] was significantly higher than that in non-DR patients [1158.1 (724.1–1838.9)] (p<0.001). The corresponding costs for mild, moderate, severe NPDR and PDR were [1167.1 (895.4–2012.0)], [2212.0 (1215.5–3825.5)], [2717.5 (1444.0–6310.7)], and [3594.8.1 (1978.4–8427.7)], respectively. After adjustment, the corresponding cost ratios for mild, moderate, severe NPDR, and PDR relative to non-DR were 1.1 (p = 0.827), 1.8 (p = 0.003), 2.0 (p = 0.031) and 2.3 (p<0.001), respectively. The other factors affecting the total cost include smoking (ratio = 1.7, p = 0.019), neuropathy (ratio = 1.9, p = 0.001) and chronic kidney disease (CKD) (ratio = 1.4, p = 0.019). The presence and severity of DR was associated with increased direct medical costs in T2DM. Our results suggest that preventing progression of DR may reduce the economic burden of DR. © 2017 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | Source Title: | PLoS ONE | URI: | https://scholarbank.nus.edu.sg/handle/10635/161185 | ISSN: | 19326203 | DOI: | 10.1371/journal.pone.0180949 | Rights: | Attribution 4.0 International |
Appears in Collections: | Elements Staff Publications |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1371_journal_pone_0180949.pdf | 911.34 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License